Canada Markets open in 1 hr 55 mins

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
154.96+2.42 (+1.59%)
At close: 04:00PM EST
159.01 +4.05 (+2.61%)
Pre-Market: 07:34AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close152.54
Bid159.50 x 900
Ask159.86 x 900
Day's Range152.80 - 165.85
52 Week Range117.34 - 497.49
Avg. Volume12,154,185
Market Cap62.829B
Beta (5Y Monthly)1.34
PE Ratio (TTM)9.28
EPS (TTM)16.69
Earnings DateFeb. 23, 2022 - Feb. 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est288.93
  • Editor's Pick
    Yahoo Finance Video

    Influencers with Andy Serwer: Gregory Zuckerman

    In this episode of Influencers, Andy is joined by ‘A Shot to Save the World’ author, Gregory Zuckerman, as they discuss the development of the COVID-19 vaccines and what the future holds for mRNA technology.

  • Editor's Pick
    Yahoo Finance Video

    The pandemic will end, but the virus isn't going away: Gregory Zuckerman

    Gregory Zuckerman, author of ‘A Shot to Save the World’, joins Yahoo Finance's Editor-in-Chief, Andy Serwer, for a discussion about what COVID-19 will look like in the future.

  • Motley Fool

    Could Vaxart's Vaccine Pill Help to End the Pandemic?

    Let's take a quick look at how Vaxart's project might be a game-changer. There are two things in Vaxart's favor regarding the chances of its pill being a pandemic-ending tool. Unlike the jabs produced by Pfizer and Moderna, Vaxart's oral tablet doesn't require skilled staff or syringes to administer, nor does it require specialized refrigerators to keep the vaccine stable.